nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Normalization, inhibition, rarefaction?
|
Morère, Jean-François |
|
2007 |
2 |
3 |
p. 133 |
artikel |
2 |
Radioimmunotherapy (RIT) in non-Hodgkin lymphoma
|
Kyle, Fiona |
|
2007 |
2 |
3 |
p. 173-179 |
artikel |
3 |
Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient
|
Medioni, Jacques |
|
2007 |
2 |
3 |
p. 193-195 |
artikel |
4 |
Role of the endothelins and endothelin receptors in cancer cell signaling and angiogenesis
|
Ghoul, Aïda |
|
2007 |
2 |
3 |
p. 181-191 |
artikel |
5 |
Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment
|
Akagi, Kiwamu |
|
2007 |
2 |
3 |
p. 145-151 |
artikel |
6 |
Targeted therapy in advanced colorectal cancer, an update
|
Tol, J. |
|
|
2 |
3 |
p. 165-172 |
artikel |
7 |
Targeted therapy in advanced colorectal cancer, an update
|
Tol, J. |
|
2007 |
2 |
3 |
p. 165-172 |
artikel |
8 |
The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts
|
Behrens, Diana |
|
2007 |
2 |
3 |
p. 135-144 |
artikel |
9 |
VEGF: a key therapeutic target for the treatment of cancer-insights into its role and pharmacological inhibition
|
Tobelem, Gérard |
|
2007 |
2 |
3 |
p. 153-164 |
artikel |